CE认证
皮肤填充剂
Neauvia Stimulate is a biodegradable hyaluronic acid filler cross-linked with PEG and enriched with calcium hydroxyapatite, manufactured by Matex Lab in Brindisi, Italy, intended to restore lost volume of the soft tissue and resorbed over time. It is placed in the subdermis and over the periosteum. The product contains 26 mg/mL of hyaluronic acid with a medium to high extrusion force, is enriched with glycine and L-proline and is intended for professional use. Neauvia's Stimulate line is the only PEG-HA plus CaHA filler on the market, and Stimulate was named Best Injectable Dermal Filler at the AMWC 2024 Awards.
主要优势： Neauvia Stimulate
- 26 mg/mL cross-linked hyaluronic acid enriched with calcium hydroxyapatite
- One of the only PEG-HA plus CaHA fillers on the market
- Named Best Injectable Dermal Filler at the AMWC 2024 Awards
- Studied over 24 weeks for correction of mid-face volume deficit
- Medium to high extrusion force, placed in the subdermis and over the periosteum
- No pathological inflammatory reactions detected so far with Neauvia PEG-HA devices
- No cytotoxic activity detected
- Reversible filling
- High resistance to heat and high thermodynamic stability, allowing combined protocols
适应症与专业用途
主要适应症
- Restoration of lost volume of the soft tissue
- Correction of mid-face volume deficit
专业用途
For professional use. Neauvia Stimulate is only to be used by physicians in accordance with local legislation, trained in the injection techniques of hyaluronic acid based fillers, and is not for retail sale or self-administration. It is placed in the subdermis and/or over the periosteum using the 21G or 22G needle or cannula supplied in the box. Its high thermodynamic stability and heat resistance are what allow it to be used within combined protocols alongside energy-based devices, and it is the filler used in Neauvia's Nlift mid-face synergistic protocol.
治疗部位
- Face
- Mid-face
适用患者
Suitable for adult patients presenting with age-related volume loss of the soft tissue, particularly mid-face volume deficit, as determined by the treating practitioner following clinical assessment. Facial ageing is a composite three-dimensional process involving bone, soft tissue and skin, in which deep fat atrophies while superficial fat repositions or hypertrophies, so the practitioner selects the grade of filler and the plane of placement according to which layer has changed.
作用原理： Neauvia Stimulate
Stimulate combines PEGylated hyaluronic acid with a low concentration of calcium hydroxyapatite. A 24-week post-market, observational, prospective, open-label, single-centre study reported that this formulation effectively addresses skin and subcutaneous tissue concerns, in particular the correction of disorders and of mid-face volume deficit, with the data highlighting an efficient mechanical effect of the PEGylated polymeric acid matrix enriched with low-concentration CaHA. Glycine and L-proline are added to the phosphate buffer solution to tune the viscoelastic properties and swelling resistance. The gel is a temporary filling, with a 6 month degradation average time.
为什么选择在 Allpara 订购
Allpara 提供正品、经过验证的 NEAUVIA 产品，来自经过严格审核的供应商，具备完整的批次可追溯性和专家支持。我们为诊所和医美专业人士提供CE认证产品、从欧盟仓库快速配送至欧盟各地，以及具有竞争力的专业价格。我们关注的是您患者的安全、满意度和效果，并提供专属售后支持，让您安心无忧。
常见问题
How does Neauvia Stimulate differ from Neauvia Intense?
Composition and plane. Neauvia Stimulate carries 26 mg/mL hyaluronic acid enriched with calcium hydroxyapatite and is placed in the subdermis or over the periosteum. Neauvia Intense carries 28 mg/mL without CaHA and is placed in the subcutis or over the periosteum. The Stimulate line is the only one in the range to combine PEG-HA with CaHA.
Why does Neauvia Stimulate contain calcium hydroxyapatite?
A 24-week post-market study of the PEGylated hyaluronic acid matrix enriched with low-concentration CaHA reported an efficient mechanical effect on skin and subcutaneous tissue, in particular for correcting mid-face volume deficit.
更多产品： Matex Lab S.P.A
美塑疗法
诊所替代选择
胶原蛋白刺激剂
/ 最近浏览
继续浏览
Neauvia Stimulate is a biodegradable hyaluronic acid filler cross-linked with PEG and enriched with calcium hydroxyapatite, manufactured by Matex Lab in Brindisi, Italy, intended to restore lost volume of the soft tissue and resorbed over time. It is placed in the subdermis and over the periosteum. The product contains 26 mg/mL of hyaluronic acid with a medium to high extrusion force, is enriched with glycine and L-proline and is intended for professional use. Neauvia's Stimulate line is the only PEG-HA plus CaHA filler on the market, and Stimulate was named Best Injectable Dermal Filler at the AMWC 2024 Awards.
主要优势： Neauvia Stimulate
- 26 mg/mL cross-linked hyaluronic acid enriched with calcium hydroxyapatite
- One of the only PEG-HA plus CaHA fillers on the market
- Named Best Injectable Dermal Filler at the AMWC 2024 Awards
- Studied over 24 weeks for correction of mid-face volume deficit
- Medium to high extrusion force, placed in the subdermis and over the periosteum
- No pathological inflammatory reactions detected so far with Neauvia PEG-HA devices
- No cytotoxic activity detected
- Reversible filling
- High resistance to heat and high thermodynamic stability, allowing combined protocols
适应症与专业用途
主要适应症
- Restoration of lost volume of the soft tissue
- Correction of mid-face volume deficit
专业用途
For professional use. Neauvia Stimulate is only to be used by physicians in accordance with local legislation, trained in the injection techniques of hyaluronic acid based fillers, and is not for retail sale or self-administration. It is placed in the subdermis and/or over the periosteum using the 21G or 22G needle or cannula supplied in the box. Its high thermodynamic stability and heat resistance are what allow it to be used within combined protocols alongside energy-based devices, and it is the filler used in Neauvia's Nlift mid-face synergistic protocol.
治疗部位
- Face
- Mid-face
适用患者
Suitable for adult patients presenting with age-related volume loss of the soft tissue, particularly mid-face volume deficit, as determined by the treating practitioner following clinical assessment. Facial ageing is a composite three-dimensional process involving bone, soft tissue and skin, in which deep fat atrophies while superficial fat repositions or hypertrophies, so the practitioner selects the grade of filler and the plane of placement according to which layer has changed.
作用原理： Neauvia Stimulate
Stimulate combines PEGylated hyaluronic acid with a low concentration of calcium hydroxyapatite. A 24-week post-market, observational, prospective, open-label, single-centre study reported that this formulation effectively addresses skin and subcutaneous tissue concerns, in particular the correction of disorders and of mid-face volume deficit, with the data highlighting an efficient mechanical effect of the PEGylated polymeric acid matrix enriched with low-concentration CaHA. Glycine and L-proline are added to the phosphate buffer solution to tune the viscoelastic properties and swelling resistance. The gel is a temporary filling, with a 6 month degradation average time.
为什么选择在 Allpara 订购
Allpara 提供正品、经过验证的 NEAUVIA 产品，具备完整的批次可追溯性、CE认证库存、欧盟范围内快速配送以及专业的售后支持。
常见问题
How does Neauvia Stimulate differ from Neauvia Intense?
Composition and plane. Neauvia Stimulate carries 26 mg/mL hyaluronic acid enriched with calcium hydroxyapatite and is placed in the subdermis or over the periosteum. Neauvia Intense carries 28 mg/mL without CaHA and is placed in the subcutis or over the periosteum. The Stimulate line is the only one in the range to combine PEG-HA with CaHA.
Why does Neauvia Stimulate contain calcium hydroxyapatite?
A 24-week post-market study of the PEGylated hyaluronic acid matrix enriched with low-concentration CaHA reported an efficient mechanical effect on skin and subcutaneous tissue, in particular for correcting mid-face volume deficit.
更多产品： Matex Lab S.P.A
查看制造商 →* 专业用途产品。包装可能因批次或市场而异。完整的使用说明和禁忌症请参阅随附的使用说明书。